Anti precocious Agent
CN β US| HS Code | Tariff Rate | Origin | Destination | Doc |
|---|---|---|---|---|
| 3004490030 | 10.0% | CN | US | Official Doc |
| 3004490005 | 10.0% | CN | US | Official Doc |
Product Images
AI Analysis
π Anti-Precocious Agents (Medicaments for Central Nervous System)
π HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Compliance Strategy
π I. Product Definition & Classification: What are "Anti-Precocious Agents"?
In the pharmaceutical trade, "Anti-Precocious Agents" typically refer to medications used to treat conditions involving early or abnormal development, often linked to hormonal imbalances or neurological issues affecting the central nervous system (CNS). In the context of the provided data, these fall under medicaments primarily affecting the central nervous system.
Key characteristics: * Therapeutic Use: Prophylactic or therapeutic use. * Formulation: Put up in measured doses (e.g., tablets, capsules, syringes) or forms/packings for retail sale (e.g., blister packs, bottles). * Active Ingredient: Contains alkaloids or their derivatives. * Classification: Specifically falls under 3004.49.00.30 (Human use) or 3004.49.00.05 (Veterinary use).
β οΈ Critical Distinction:
- If the product is not in measured doses or retail packaging (e.g., bulk powder for further manufacturing) β It may fall under Chapter 29 (Chemical Products) instead of Chapter 30.
- If it contains biological products (e.g., hormones from blood/serum) β It may fall under 3002 (Excluded per heading note).
- Human vs. Veterinary: The HS Code differs significantly based on the end-user.
π¦ II. HS Code Classification Details (2026 Latest Tariff Authority Cross-Reference)
| HS Code | Product Description | Intended Use | Key Components |
|---|---|---|---|
3004.49.00.30 |
Medicaments primarily affecting the CNS: Antidepressants, tranquilizers, and other psychotherapeutic agents (Other, containing alkaloids) | Human Use | Alkaloids/derivatives; retail/measured dose |
3004.49.00.05 |
Medicaments containing alkaloids or derivatives thereof: For veterinary use | Veterinary Use | Alkaloids/derivatives; retail/measured dose |
π Key Note:
- Both codes are under Heading 3004: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses...
- "Anti-Precocious" is a therapeutic description, not a chemical name. The classification relies on HS Code structure (3004.49.00) which captures "Other" medicaments containing alkaloids.
π° III. 2026 Latest Tariff Rate Breakdown
β Applicable Country: United States (US)
β Origin: China (CN) [Assumed based on typical trade context; adjust if origin differs]
β Effective Date: Current as of 2026 tariff schedules
π― 1. 3004.49.00.30 ββ Human Medicaments (CNS Effects)
| Item | Content |
|---|---|
| Basic Tariff | 0.0% |
| Additional Tariff (301/IEEPA) | 0.0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value Γ 0% = $0 |
| De Minimis Exemption | β Yes (If value β€ $800, no duties/taxes apply under Section 321) |
| Legal Basis | HTSUS 3004.49.00.30 |
π Explanation:
- Human medicinal products containing alkaloids, when properly classified under 3004.49.00.30, currently enjoy 0% duty under current US trade policy.
- No additional 301 tariffs or IEEPA surcharges apply to this specific subheading for Chinese origin.
- Compliance Alert: Must ensure the product is not a biological product (3002) or a cosmetic/device (3005/3006).
π― 2. 3004.49.00.05 ββ Veterinary Medicaments (Alkaloids)
| Item | Content |
|---|---|
| Basic Tariff | 0.0% |
| Additional Tariff (301/IEEPA) | 0.0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value Γ 0% = $0 |
| De Minimis Exemption | β Yes (If value β€ $800) |
| Legal Basis | HTSUS 3004.49.00.05 |
π Explanation:
- Veterinary medicaments also benefit from 0% duty in this category.
- Strict Labeling: Must clearly state "For Veterinary Use Only" on packaging and commercial invoice to avoid misclassification as human medicine.
π οΈ IV. Customs Clearance Practical Advice (Battle-Tested Pitfall Guide)
β 1. Required Documentation Checklist (Non-Negotiable)
| Document | Mandatory? | Details |
|---|---|---|
| β Commercial Invoice | βοΈ | Must specify: "Medicaments containing alkaloids, put up in measured doses for [Human/Veterinary] use" |
| β Product Specification Sheet | βοΈ | List active ingredients (alkaloids), dosage form, and therapeutic indication |
| β FDA Registration/DNIs | βοΈ | Human: FDA Drug Listing & Establishment Registration; Veterinary: FDA CVM registration |
| β Certificate of Analysis (COA) | βοΈ | Confirms alkaloid content and purity |
| β Import License (if applicable) | βοΈ | Some alkaloid-based drugs may require additional FDA permits |
| β Labeling Compliance | βοΈ | Must match US labeling standards (NDC for human, FDC for vet) |
β 2. Declaration Tips (Key Mantras)
π₯ "Clear Use Case, Precise Alkaloid Mention, Dose Form Defined, Zero Duty Achieved!"
| Scenario | Correct Declaration | Incorrect Practice |
|---|---|---|
| Human CNS Medicament | 3004.49.00.30 β "Human medicament, CNS effect, alkaloid-based, retail pack" |
Vague: "Health Supplement" β May be flagged as unapproved drug |
| Veterinary Medicament | 3004.49.00.05 β "Veterinary medicament, alkaloid-based" |
Misclassified as human drug β FDA seizure + penalties |
| Bulk Powder | NOT 3004 β Likely 2939 (Alkaloids) | Declaring as 3004 β Rejected for not being "put up for retail" |
β 3. Special Cases & Mitigation
| Case | Handling Advice |
|---|---|
| Alkaloid Source | If alkaloid is synthetic vs. natural, ensure consistent HS code (both fall under 3004.49) |
| Combination Products | If contains non-alkaloid ingredients, still falls under 3004 if alkaloid is primary active |
| Clinical Samples | For samples not for sale, may qualify for exemption under specific FDA pathways |
| Misdeclaration Risk | Using terms like "Supplement" or "Herbal Tea" for medicinal alkaloids β High audit risk |
π V. Global Market Customs Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Duty Rate | Regulatory Body | Notes |
|---|---|---|---|---|
| πΊπΈ USA | 3004.49.00.30 / .05 |
0% | FDA | Must comply with FD&C Act |
| π¨π³ China | 3004.49 (approx.) | 0-5% | NMPA | Import license required |
| πͺπΊ EU | 3004.90 (varies) | 0% | EMA | Marketing Authorization needed |
| π¬π§ UK | 3004.90 (varies) | 0% | MHRA | Post-Brexit rules apply |
| π―π΅ Japan | 3004.90 (varies) | 0-10% | PMDA | Requires Yakkan license |
π Conclusion:
- USA offers the most transparent and duty-free entry for these specific HS codes, provided regulatory compliance (FDA) is met.
- Zero tariff does not mean zero regulation β FDA approval is mandatory.
π VI. Common Errors & Pitfall Guide (Lessons Learned)
β Error 1: Declaring as "Dietary Supplement" (HS 2106)
π Consequence: FDA rejection + detention if labeled as therapeutic. Supplements cannot claim to treat diseases.
β Error 2: Using generic term "Herbal Medicine" without specifying alkaloid content
π Consequence: Misclassification risk; customs may apply higher duties or require additional testing.
β Error 3: Mixing Human and Veterinary shipments in one declaration
π Consequence: Customs rejection; separate clearances required.
β Error 4: Ignoring "Measured Dose" requirement
π Consequence: If not in retail/measured form, HS Code changes to 2939 (Chemical products), altering duty structure.
β Correct Declaration Example:
"Human Medicament: Antidepressant agent containing alkaloid derivatives, 10mg tablets, blister pack for retail sale, FDA-approved, HS 3004.49.00.30"
π― VII. Conclusion: Professional Declaration, Safe Passage, Cost Efficiency!
π― Remember Mantras:
πΉ "Human use, 30.49.30; Vet use, 30.49.05; Both zero duty if declared right!"
πΉ "Alkaloid-based, retail-packaged, CNS-targeted β the golden trio for 0% duty!"
π Pro Tip:
- Always pre-clear with FDA if the product is new to the US market.
- For shipments under $800, leverage Section 321 de minimis exemption for faster clearance.
- Keep COA and FDA registration documents readily accessible for customs audits.
π£ Immediate Action:
π Consult a licensed customs broker + Provide FDA approval docs + Ensure precise HS Code declaration
π Ensure smooth customs clearance, regulatory compliance, and cost savings!
β¨ Professional Clearance Starts with Accurate Classification!
πΌ Every penny saved in duties is pure profit!
Customer Reviews
About HS Code Classification
The Harmonized System (HS) is an internationally standardized nomenclature developed by the World Customs Organization (WCO) to classify traded products. Over 200 countries use the HS system as the basis for customs tariffs, trade statistics, and import/export regulations.
Each HS code follows a hierarchical structure:
- Chapter (2 digits) β Broad category of goods (e.g., Chapter 84: Machinery and Mechanical Appliances)
- Heading (4 digits) β More specific grouping within the chapter
- Subheading (6 digits) β Internationally standardized breakdown, used by all WCO member countries
- National subdivisions (8-10 digits) β Country-specific extensions for further classification, such as US HTSUS 10-digit codes
Correct HS code classification is essential for smooth customs clearance, accurate duty payment, and compliance with trade regulations. Misclassification can lead to customs delays, overpayment of duties, or penalties.
When importing from CN to US, the applicable tariff rates may include:
- Most-Favored-Nation (MFN) rate β The standard duty rate applied to WTO members
- General rate β Applied to countries without trade agreements
- Trade remedy duties β Additional tariffs such as Section 301 (anti-dumping), Section 232 (national security), or countervailing duties
The information provided on this page is for reference purposes only. For official classification, please consult with your local customs authority or a licensed customs broker.